Ophthalmology 2024 Update
Private equity’s investments in ophthalmology are entering a new, more ...
The Valuation Hierarchy of Direct-to-Consumer Businesses in Private Equity
In the dynamic realm of direct-to-consumer (DTC) businesses, a clear ...
2024 M&A Outlook – Navigating Evolving Market Dynamics
Private Equity buyers led deal making in 2023, and are ...
2023 FOCUS Year in Review
With 2024 in full swing, we take a quick ...
Owners: Keep your eye on your equity!
Precision machine shop owners are experiencing high demand for their services. With the economy re-opening orders are piling up. One of the biggest problem is keeping up with that demand. However, that does not necessarily mean business is destined to continue to get more valuable as revenue grows. This article explores this topic and encourages precision machine owners to consider the big picture.
Photonics Series
For the past five years at least we have watched ...
Interview with Rick Thomas CEO and Chief Outdoor Enthusiast of FOCUS
As a member of our automotive aftermarket team, Rick Thomas, FOCUS CEO, has led our firm’s expansion into overlanding by helping several companies raise capital by selling all or parts of their businesses. As an overlanding enthusiast himself, Rick identified overlanding as a growth category for our firm so internally we have branded him as our ‘COE - Chief Outdoor Enthusiast’. In a recent interview, Rick discusses his personal connection to overlanding and how FOCUS helps firms in the industry.
What is the Value of my Medical Practice?
This article focuses on how medical practices are valued by ...
Private Equity Interest in Orthopedics Grows
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. But that’s been changing over the past few years and is likely to continue to grow moving forward.
Private Equity’s Increasing Consolidation of Oncology Practices
On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 billion. AmerisourceBergen, the big drug wholesaler, is buying a minority stake in the firm; OneOncology’s affiliated practices, physicians, and management team will also retain a minority interest.
